Platinum Sponsors
AstraZeneca
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
- www.astrazeneca.com
- Booth no. 2:D2
Janssen Oncology
At Janssen Oncology, our purpose is to make cancer a manageable and, ultimately, curable condition. We understand that the power to change the lives of those living with cancer begins with a very considered step forwards. Whether it’s from finding novel solution, a new indication approval, or even just reaching one more patient. That’s The Power of Purpose™.
- www.janssen.com
- Booth no. 2:G2
Gold Sponsors
Gilead
Gilead Oncology are creating the future of oncology. From antibody-drug conjugates and small molecules to cell therapy-based approaches, our research and development programs and partnerships are creating possibilities for people with cancer. We are helping to bring more life to people with cancer.
- www.gilead.com
- Booth no. 2:F2
Regeneron
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and product candidates in development. Visit www.Regeneron.com to learn more.
- www.regeneron.com
- Booth no. 2:C2
Silver Sponsors
Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies and has reached millions of patients globally.
- www.amgen.com
- Booth no. 2:A5
Daiichi Sankyo Europe GmbH
Daiichi Sankyo is an innovative global healthcare company that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With over 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.
- www.daiichi-sankyo.eu
- Booth no. 2:F1
MSD
At MSD we use the power of leading-edge science to save and improve lives. We aspire to be the premier research-intensive biopharmaceutical company in the world. We are at the forefront of research, delivering innovative health solutions that advance disease prevention and treatment. We foster a diverse and inclusive workforce, operating responsibly to enable a safe, sustainable and healthy future.
- www.msd.com
- Booth no. 2:H1
Pfizer Oncology
Pfizer Oncology is at the forefront of a new era in cancer care. Driven by science, we are committed to accelerating breakthroughs to extend and improve the lives of people living with some of the world’s most common cancers.
- www.pfizer.com
- Booth no. 2:C1
Bronze Sponsors
Novocure GmbH
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms.
- www.novocure.com
- Booth no. 2:E2
Seagen
Seagen is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary antibody-drug conjugates and immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors.
- www.seagen.com
- Booth no. 2:C4
Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. We are enabling precision oncology with easily implementable next-generation sequencing (NGS) Oncomine™ Solutions. Our latest development, the Genexus Dx system, offers a highly automated end-to-end workflow and enables laboratories to deliver NGS results in as little as one day, at the same time as methods like immunohistochemistry, making NGS more accessible than ever before.
- www.thermofisher.com
- Booth no. 2:A2
Sponsor
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
Exhibitors
Accord Healthcare
Headquartered in the United Kingdom, Accord Healthcare is a fast-growing global pharmaceutical company that develops, manufactures and distributes medicines in over 85 countries worldwide, helping to improve access for patients to vital pharmaceutical care. Our approach is agile and inventive, we’re driven to think differently by continuing to explore and deliver high quality medicines designed to benefit patients’ lives worldwide.
- www.accord-healthcare.com
- Booth no. 2:I1
BeiGene Switzerland GmbH
BeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them.
- www.beigene.com
- Booth no. 2:C3
Genmab Inc
Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer and other serious diseases. Genmab’s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. For more information, please visit our website and follow us on Twitter.
- www.genmab.com
- Booth no. 2:A1
PharmaMar
PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. PharmaMar develops and commercializes Yondelis® in Europe. PharmaMar is also developing lurbinectedin in SCLC. It has been approved in 13 countries, including USA and Switzerland for the treatment of metastatic SCLC.
- www.pharmamar.com
- Booth no. 2:D3
Pierre Fabre Laboratoires
Pierre Fabre is a French company with 40 years of experience in oncology. It dedicated 80% of its R&D spendings to oncology in 2022 and declared targeted therapies as its R&D priority. Its portfolio covers colorectal, breast and lung cancers, melanoma, hematology, pre-cancerous skin conditions.
- www.pierre-fabre.com
- Booth no. 2:D4
Revolution Medicines
At Revolution Medicines, we believe in challenging the status quo to find new therapeutic approaches to some of the toughest cancers. With our first wave of investigational RAS(ON) inhibitors, we are pioneering a new way of targeting the RAS cancer drivers of disease, and we have the potential to change the treatment paradigm in these cancers.
- www.revmed.com
- Booth no. 2:K3
Roche
Roche is a pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, hematology and beyond.
- www.roche.com
- Booth no. 2:E1
SamanTree Medical
SamanTree Medical has developed a breakthrough medical imaging modality that enables new medical procedures with the will to improve cancer treatment. The Histolog® Scanner provides high resolution imaging of the surface of fresh tissue. Based on a novel ultra-fast confocal microscopy technology invented in EPFL in 2010, it finds its application along the patient journey, from biopsy to surgical diagnostics.
- www.samantree.com
- Booth no. 2:H4
Publisher
Wisepress Medical Bookshop
Wisepress.com is Europe’s leading conference bookseller. We have an extensive range of books and journals relevant to the themes of this conference available at our booth. We also have a comprehensive range of STM titles available on our online bookshop. Follow us on Twitter @WisepressBooks.
- www.wisepress.com
- Booth no. 2:A3
Society
Lung Cancer Europe (LuCE)
Lung Cancer Europe (LuCE) is the umbrella organization uniting patient associations and networks across Europe with a mission to amplify the voice of those impacted by lung cancer and their families, and to support advocacy and collaboration towards ensuring improved access to care and reduced stigma.
- www.lungcancereurope.eu
- Both no. 2:K2
